Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: A multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
In clinical trials examining GLP-1 RA in combination with a sulphonylurea (with or without metformin) or insulin, the incidence of hypoglycemia was low overall, but increased when compared with placebo [114]
Your diet quality makes a difference
This study aims to summarize the current information on the mechanisms and effects of GLP-1R agonists in AD
We found that oral administration of FEX could lower the levels of GLP-1 and insulin and increase the blood glucose levels without changing BW in MMI mice receiving T3 treatment (Fig
Our team helps clinics and health professionals design, build, and scale GLP-1 weight-loss platforms